Research Articles on Tuberculosis from 1940 onwards

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action
New diagnostic tests for tuberculosis: bench, bedside, and beyond.
Clin Infect Dis. 2010 May 15;50 Suppl 3:S173-7.
Implications of the global increase of diabetes for tuberculosis control and patient care.
Trop Med Int Health. 2010 Nov;15(11):1289-99.
Exit from dormancy in microbial organisms.
Nat Rev Microbiol. 2010 Dec;8(12):890-6.
In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
J Med Microbiol. 2010 May;59(Pt 5):567-72.
Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns.
Int J Antimicrob Agents. 2010 Jun;35(6):519-23.
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacteriumtuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.
J Infect Dis. 2010 Apr 15;201(8):1225-31.
Allelic exchange and mutant selection demonstrate that common clinical embCAB genemutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2010 Jan;54(1):103-8.
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugsand ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
J Clin Microbiol. 2010 May;48(5):1683-9.
Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.
Antimicrob Agents Chemother. 2010 Sep;54(9):3776-82.